NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT05017610 2022-12-02Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or GliosarcomaEmory UniversityPhase EARLY_PHASE1 Withdrawn
NCT04891718 2022-07-08CIVO Intratumoural Microdosing of Anti-Cancer Therapies in AustraliaPresage BiosciencesPhase EARLY_PHASE1 Withdrawn